Temocillin
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.060.148 |
| Chemical and physical data | |
| Formula | C16H18N2O7S2 |
| Molar mass | 414.45 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Temocillin is a β-lactamase-resistant penicillin[1][2] introduced by Beecham, marketed by Eumedica Pharmaceuticals as Negaban. It is used primarily for the treatment of multiple drug-resistant, Gram-negative bacteria.
It is actually a 6-methoxy Ticarcillin; it is also a carboxypenicillin.[3]
- ^ Andrews JM, Jevons G, Walker R, Ashby J, Fraise AP (July 2007). "Temocillin susceptibility by BSAC methodology". The Journal of Antimicrobial Chemotherapy. 60 (1): 185–187. doi:10.1093/jac/dkm179. PMID 17550891.
- ^ Van Landuyt HW, Pyckavet M, Lambert A, Boelaert J (October 1982). "In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic". Antimicrobial Agents and Chemotherapy. 22 (4): 535–540. doi:10.1128/aac.22.4.535. PMC 183789. PMID 7181470.
- ^ Chanal M, Sirot J, Cluzel M, Joly B, Glanddier Y (June 1983). "[In vitro study of the bacteriostatic and bactericidal activity of temocillin (BRL 17421)]". Pathologie-Biologie (in French). 31 (6): 467–470. PMID 6348653.